SANTHERA PHARMA

The current price of S3F0 is 9.411 CHF — it has decreased by 1.67% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on BX exchange SANTHERA PHARMA stocks are traded under the ticker S3F0.

SANTHERA PHARMA is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.

S3F0 stock is 1.70% volatile and has beta coefficient of −1.01. Check out the list of the most volatile stocks — is SANTHERA PHARMA there?

Yes, you can track SANTHERA PHARMA financials in yearly and quarterly reports right on TradingView.

S3F0 stock has fallen by 1.57% compared to the previous week, the month change is a 11.58% fall, over the last year SANTHERA PHARMA has showed a 16.19% increase.

Today SANTHERA PHARMA has the market capitalization of ‪107.54 M‬, it has increased by 5.01% over the last week.

No, S3F0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, S3F0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANTHERA PHARMA stock right from TradingView charts — choose your broker and connect to your account.

S3F0 reached its all-time high on Oct 19, 2023 with the price of 13.554 CHF, and its all-time low was 7.285 CHF and was reached on Oct 11, 2023.
See other stocks reaching their highest and lowest prices.

We've gathered analysts' opinions on SANTHERA PHARMA future price: according to them, S3F0 price has a max estimate of 30.00 CHF and a min estimate of 13.00 CHF. Read a more detailed SANTHERA PHARMA forecast: see what analysts think of SANTHERA PHARMA and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANTHERA PHARMA EBITDA is ‪53.54 M‬ CHF, and current EBITDA margin is 51.79%. See more stats in SANTHERA PHARMA financial statements.